Sponsor pipeline

Genoss Co., Ltd. clinical trial pipeline

Get alerts when Genoss Co., Ltd.'s trials change

13 active trials 5 recruiting 1 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Notable

DCBMultivessel · Impact of DCB-based Versus DES-based Intervention · MVCAD

Recruitment opened

Also in this update: Completion pushed from Jul 31, 2032 to Dec 31, 2032; Interventions modified

Genoss Co., Ltd.Not applicable NCT07539324 Registry history of NCT07539324 on ClinicalTrials.gov (opens the registry)

Updated Oct 9, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Not charted: 13 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT ID	Title	Condition	Status	Updated
Not applicable
NCT07539324	Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD	Multi Vessel Coronary Artery Disease	Recruiting	2026-10-09
NCT07159087	The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus…	Coronary Arterial Disease (CAD)	Enrolling by Invitation	2025-09-08
Not specified
NCT07425171	Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion	PTA (Percutaneous Transluminal Angioplasty)	Recruiting	2026-09-11
NCT06075420	Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients…	Percutaneous Coronary Intervention	Recruiting	2025-02-21
NCT06075433	Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients…	Coronary Artery Disease	Recruiting	2025-02-21
NCT06066450	Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis	Drug-eluting Stent	Recruiting	2023-11-01
NCT07431437	One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease	PTA (Percutaneous Transluminal Angioplasty)	Enrolling by Invitation	2026-09-11
NCT07399080	Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease	PTA (Percutaneous Transluminal Angioplasty )	Enrolling by Invitation	2026-02-18
NCT06075368	Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)	Acute Coronary Syndrome	Active, Not Recruiting	2026-02-11
NCT06086496	Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent…	Coronary Artery Disease	Enrolling by Invitation	2025-10-06
NCT06168305	Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery…	Percutaneous Coronary Intervention	Enrolling by Invitation	2025-10-06
NCT06841510	Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease	Coronary Arterial Disease (CAD)	Active, Not Recruiting	2025-09-16
NCT07158307	Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients…	Coronary Artery Disease(CAD)	Enrolling by Invitation	2025-09-05

Disease areas by active trials

Coronary Artery Disease (9)

Get alerts when Genoss Co., Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free